Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

ImmuPharma Plc

Sector: Commercial Physical And Biological Research Region: United Kingdom


Exchange/Ticker: London Stock Exchange: IMM


Company Description

ImmuPharma Plc is a drug discovery and development company, which is focused on developing novel medicines to treat serious medical conditions and address a high unmet need. The company develops drugs to treat lupus, cancer, severe pain, highly resistant infections like MRSA and inflammatory and allergic disorders. It has research operations in France and Switzerland. ImmuPharma was founded by Richard Warr in 1999 and is headquartered in London, the United Kingdom.

Similar to: Medivir AB, Exelixis, Inc., Advanced Cell Technology, Inc.

Featured Company


Fidelity Asian Values Plc

Tadworth, SU, GB

Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →

You may also be interested in:


Advanced Cell Technology,…

Marlborough, MA, US

Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →

Exelixis, Inc.

South San Francisco, CA, US

Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →

Medivir AB

Stockholm, SE

Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →